Skip to main content

Table 4 Odds ratio (OR) and relative risk (RR) and 95% confidence intervals (CI) for the EPO SNP rs1617640 in AML and MDS patients with complete clinical data.

From: Significant association between polymorphism of the erythropoietin gene promoter and myelodysplastic syndrome

 

Odd Ratio

95%CI

Risk Ratio

95%CI

MDS vs AML

   

T/T

0.82

0.51-1.34

0.88

0.65-1.20

G/G

2.25

1.24-4.09

1.58

1.17-2.14

G/T

0.72

0.45-1.17

0.82

0.60-1.11

MDS vs Normal

   

T/T

0.54

0.31-0.95

0.75

0.57-0.99

G/G

5.18

2.05-13.12

1.72

1.38-2.13

G/T

0.82

0.47-1.43

0.91

0.70-1.18

AML vs Normal

   

T/T

0.66

0.40-1.09

0.87

0.73-1.03

G/G

2.3

0.91-5.83

1.25

1.03-1.52

G/T

1.13

0.69-1.86

1.04

0.88-1.23

Back to article page

BMC Medical Genetics

ISSN: 1471-2350

Contact us